Mounjaro Shortage by State Tracker October 2026
Pharmaceutical availability gaps are still affecting patients across the US. This page provides up-to-date tracking on availability and alternatives.
Stock Status
Currently, the shortage situation for GLP-1 medications varies significantly by:
- Specific medication and strength: Initial titration doses are typically in better supply than maintenance doses
- Geographic location: Distribution networks send more stock to major metro regions while less populated regions face more difficulty
- Pharmacy type: Non-chain pharmacies may stock doses unavailable at big retailers
Dose-Specific Tracking
Starter and Low Doses
Initial titration products are generally easier to find because:
- A smaller population uses starting strength long-term
- Drug makers focus production on initial supply to ensure new patient access
Target Strengths
Target dosing face more pressure because:
- Most patients graduate to maintenance dosing and continue long-term
- Manufacturing can’t keep up as more patients titrate up
Action Plan
First Actions
- Call ahead — never drive to a pharmacy without calling availability
- Cast a wide net — try several pharmacies across different chains
- Ask about waiting lists — many pharmacies will call upon receiving a shipment
Extended Supply Issues
- Talk to your prescriber about temporary changes — they may authorize a different strength
- Consider compounded options — when your medication is on the FDA shortage list, compounded alternatives may be accessed
- Check manufacturer assistance — both Novo Nordisk and Eli Lilly provide programs to help patients find supply
Monitoring Resources
Use these resources to keep current:
- The official FDA list — the most reliable data
- Novo Nordisk and Eli Lilly — availability information straight from the source
- CVS/Walgreens/Walmart apps — may display medication status
- Support groups — community members report live where they found it
New data is added as conditions change.